trending Market Intelligence /marketintelligence/en/news-insights/trending/o3O7_FLKVNOO36JJxrO8YA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Evolent Health offering $175M of common shares

Amid Q1 APAC Fintech Funding Slump, Payment Companies Drove Investments

Paypal Well-Positioned To Gain Share In COVID-Related Digital Payments Shift

Digital Banking Battles Will Play Out In Southeast Asias Shopping Cart

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible

Evolent Health offering $175M of common shares

Evolent Health Inc. has announced the launch of a proposed public offering of $175 million of its class A common shares registered under a shelf statement.

The company expects to grant the underwriters a 30-day option to purchase an additional $26.3 million of its class A common shares. All shares will be offered by the company.

Evolent Health plans to transfer the net proceeds from this offering to its subsidiary, Evolent Health LLC, which is expected to use the net proceeds for working capital and other general corporate purposes, including to expand its business through acquisitions and investments.

J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC are acting as joint book-running managers and as representatives of the underwriters for the offering. Wells Fargo Securities LLC, William Blair & Co. LLC and SunTrust Robinson Humphrey Inc. are acting as lead managers, while Leerink Partners LLC and Robert W. Baird & Co. Inc. are acting as co-managers.